Today: 13 May 2026
DGXX Stock: Digi Power X’s $175 Million Share Plan Puts Its Cerebras AI Data Center Bet on Trial
11 May 2026
2 mins read

DGXX Stock: Digi Power X’s $175 Million Share Plan Puts Its Cerebras AI Data Center Bet on Trial

MIAMI, May 11, 2026, 06:01 EDT

Digi Power X Inc. boosted its at-the-market share-sale program to a maximum of $175 million, just days after locking in a 40-megawatt data center deal with Cerebras Systems. The Nasdaq-listed AI infrastructure firm said any shares sold will be issued stateside via A.G.P./Alliance Global Partners.

Digi’s timing is crucial: the company is repurposing old crypto-mining sites into AI-focused, power-hungry data centers, right as investor appetite for AI infrastructure stays hot. Its latest customer, Cerebras, could bump up both the price range and size of its IPO as early as Monday, according to Reuters, which cited sources saying orders are running at more than 20 times what’s on offer.

An at-the-market offering—ATM for short—allows a company to gradually sell its shares on public markets at whatever the current price is. Digi said proceeds could end up funding a mix of things: general corporate uses, shoring up working capital, building out a Tier 3 data center, reducing debt, or maybe even acquisitions. For context, Tier 3 points to a data center standard focused on reliability, with extra backup systems built in.

The prospectus supplement tacks on another $100 million to the program, which originally stood at $75 million. Out of that earlier allotment, Digi had already moved $72.36 million. With the new filing, the company heads into Monday’s U.S. session with a much larger financing tool on the table.

Digi ended Friday’s session at $6.63, climbing 7.1%. That puts the stock just shy of its 52-week quoted high of $6.80. Based on available quote data, the company’s market cap stood at roughly $462.8 million.

DGXX stock has grabbed attention mostly because of the Cerebras deal. According to a filing dated May 8, Digi reached an agreement on May 4 to deploy about 40 MW of AI computing power at its Columbiana, Alabama site. The plan calls for 15 MW to be up and running by December 15, 2026, with the full 40 MW slated for completion by the close of the first quarter of 2027.

The deal runs for an initial 10 years, valued at roughly $1.1 billion, and could reach around $2.5 billion if extended another seven years. A planned second phase—25 MW more—hinges on Digi lining up enough financing.

Michel Amar, who serves as both chairman and chief executive at Digi, described the Cerebras agreement as “transformational.” President Alec Amar put it another way, calling it “a statement.” Hans Vestberg — a senior adviser at Digi and formerly Verizon’s chief executive — pointed to high-density AI infrastructure as one of this period’s big buildout challenges.

Digi kicked off 2026 with limited revenue, still well below its buildout ambitions. For 2025, it logged $34.2 million in revenue and posted a GAAP net loss of $28.4 million. Cash stood at $78.5 million, digital-currency assets at $14.8 million. The company called out its pivot away from crypto mining, now targeting AI infrastructure, GPU-as-a-service, and colocation.

Things are accelerating. Just last week, Hut 8 locked in a $9.8 billion, 15-year lease for a 352 MW data center phase in Texas. Nvidia, for its part, is putting as much as $2.1 billion into data center firm IREN, aiming to roll out as much as 5 gigawatts of AI infrastructure. Digi’s Alabama build is only 40 MW—much smaller—but it’s chasing the same pinch point: power and space for AI hardware.

Execution and dilution loom as the key issues here. Digi needs to get the site built, outfitted, actually up and running—none of that is locked in yet, and phase two isn’t a given. The company’s own prospectus flagged its shares as a speculative bet and flagged plenty of risks. Selling stock through the ATM could bump up the share count, all depending on when and at what price they move it.

A.G.P. stands to collect a 3% commission on any shares sold through the program, according to the prospectus supplement. Digi isn’t locked into selling stock—it can pause or end sales whenever—but the filing carves out room should the company need cash to push ahead with a buildout; full revenue isn’t expected until the 40 MW deployment wraps up in early 2027.

Stock Market Today

  • Venture Global Stock Analysis: Valuation Amid Volatility
    May 12, 2026, 6:04 PM EDT. Venture Global (VG) shares have shown recent volatility, rising 1.5% in the latest session but down 15.6% over the past week. Over three months, VG gained 14.6%, with a strong year-to-date return of 65.1%. Trading at $11.62, the stock sits 55.7% below one intrinsic value estimate and 26.8% under an analyst target, suggesting a potential 5.3% undervaluation with a fair value around $12.26. The company's liquefied natural gas (LNG) business benefits from global energy shifts away from coal and Russian gas pipelines, bolstering long-term earnings forecasts. Risks include arbitration outcomes at Calcasieu Pass and project cost increases at Plaquemines and CP2 that could affect competitiveness. Investors are urged to balance these factors amid market uncertainty and evaluate additional LNG-linked opportunities.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Novo Nordisk Shares Rise As Ozempic Study Shows 15% Weight Loss In Older Adults
Previous Story

Novo Nordisk Shares Rise As Ozempic Study Shows 15% Weight Loss In Older Adults

AST SpaceMobile Stock Faces Big Monday Test After FCC Win and BlueBird 7 Setback
Next Story

AST SpaceMobile Stock Faces Big Monday Test After FCC Win and BlueBird 7 Setback

Go toTop